Fc‐Fusion proteins represent a successful class of biopharmaceutical products, with already
13 drugs approved in the European Union and United States as well as three biosimilar …

Biopharmaceuticals are one of the fastest-growing sectors in the biotechnology industry.
Within the umbrella of biopharmaceuticals, the biosimilar segment is expanding with …

The main objective of this work was to explore the feasibility to print monoclonal antibody
(mAb)-loaded implantable systems using fused-deposition modelling (FDM) to build …

Monoclonal antibodies-based medicines are widely used in the treatment of different
diseases. These medicines are very sensitive to exposure to different environmental …

Nivolumab, formulated in the medicine Opdivo®(10 mg/mL), is a therapeutic monoclonal
antibody (mAb) used in the treatment of different types of cancer. Currently, there is …

Teduglutide (Revestive®) is a glucagon-like peptide-2 analogue used for the treatment of
short bowel syndrome, a rare life-threatening condition in which the amount of functional gut …

Background/Objectives: Cetuximab, formulated in Erbitux®(5 mg/mL), is a therapeutic
monoclonal antibody (mAb) widely used in several cancer treatments. Currently, there is …

COVID-19, a disease caused by the novel coronavirus SARS-CoV-2, has produced a
serious emergency for global public health, placing enormous stress on national health …

Aflibercept is a recombinant fusion protein that is commercially available for several ocular
diseases impacting millions of people worldwide. Here, we use a case study approach to …

Purpose It has been reported that intravitreal Ziv-aflibercept is a safe and effective drug for
the treatment of diabetes macular edema (DME). The objective of this study was to evaluate …